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Streptococcus pyogenes is one of the most significant bacterial pathogens in the human
population mostly causing superficial and uncomplicated infections (pharyngitis and
impetigo) but also invasive and life-threatening disease. We have previously identified
a virulence determinant, protein sHIP, which is secreted at higher levels by an invasive
compared to a non-invasive strain of S. pyogenes. The present work presents a further
characterization of the structural and functional properties of this bacterial protein.
Biophysical and structural studies have shown that protein sHIP forms stable tetramers
both in the crystal and in solution. The tetramers are composed of four helix-loop-helix
motifs with the loop regions connecting the helices displaying a high degree of flexibility.
Owing to interactions at the tetramer interface, the observed tetramer can be described
as a dimer of dimers. We identified three residues at the tetramer interface (Leu84, Leu88,
Tyr95), which due to largely non-polar side-chains, could be important determinants for
protein oligomerization. Based on these observations, we produced a sHIP variant in
which these residues weremutated to alanines. Biophysical experiments clearly indicated
that the sHIP mutant appear only as dimers in solution confirming the importance of
the interfacial residues for protein oligomerisation. Furthermore, we could show that the
sHIP mutant interacts with intact histidine-rich glycoprotein (HRG) and the histidine-rich
repeats in HRG, and inhibits their antibacterial activity to the same or even higher extent
as compared to the wild type protein sHIP. We determined the crystal structure of the
sHIP mutant, which, as a result of the high quality of the data, allowed us to improve
the existing structural model of the protein. Finally, by employing NMR spectroscopy
in solution, we generated a model for the complex between the sHIP mutant and
an HRG-derived heparin-binding peptide, providing further molecular details into the
interactions involving protein sHIP.
Keywords: proteomics, structural biology, virulence factors, protein-protein interactions, host-pathogen
relationship
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INTRODUCTION
Streptococcus pyogenes, also known as group A streptococci
(GAS) is a significant human pathogen that infects and colonizes
the skin and the upper respiratory tract where it causes relatively
mild clinical conditions such as impetigo and pharyngitis. Some
infections caused by invasive strains, such as the AP1 strain of the
M1 serotype, can lead to severe and potentially life-threatening
diseases such as necrotizing fasciitis and streptococcal toxic
shock syndrome (STSS), whereas acute rheumatic fever and
glomerulonephritis are sequelae to acute S. pyogenes infections.
S. pyogenes causes an estimated 700 million cases of mild and
non-invasive infections each year, of which ∼650,000 progress
to severe invasive infections with a mortality of at least 25%
(Carapetis et al., 2005; Ralph and Carapetis, 2013). S. pyogenes
produces a number of proteins that enable the bacterium to
attach to host tissues, evade the immune response, and spread
by penetrating host tissue layers. These virulence factors are
predominantly secreted or surface associated proteins, and they
include the family ofM proteins (Lancefield, 1962; Swanson et al.,
1969; Phillips et al., 1981), fibronectin-binding proteins (Talay
et al., 1994; Kreikemeyer et al., 1995; Jaffe et al., 1996; Courtney
et al., 1999; Rocha and Fischetti, 1999; Terao et al., 2001), super-
antigenic exotoxins (Stevens et al., 1989; Abe et al., 1991; Tomai
et al., 1992; Mollick et al., 1993; Norrby-Teglund et al., 1994), and
the secreted streptococcal inhibitor of complement referred to as
protein SIC (Åkesson et al., 1996; Fernie-King et al., 2002; Frick
et al., 2003).
In a recent study, we quantitatively analyzed and compared
S. pyogenes proteins in the growth medium of a strain that is
virulent to mice (AP1), with a non-virulent strain (SF370). We
found that one protein in particular was present at significantly
higher levels in the stationary growth medium from the virulent
strain. The amount of sHIP in the medium fraction is similar
to the secreted mitogenic exotoxin SmeZ (Kamezawa et al.,
1997), and shows an overall abundance profile resembling the
profile observed for the surface associated proteins H and
M1 (Lancefield, 1962; Åkesson et al., 1990; Wisniewska et al.,
2014). Through the use of affinity pull-down mass spectrometry
analysis of human plasma, we could demonstrate that the
new bacterial protein interacts with the antimicrobial human
protein histidine-rich glycoprotein (HRG), and the name sHIP
(streptococcal Histidine-rich glycoprotein Interacting Protein)
was therefore introduced (Wisniewska et al., 2014). HRG is an
abundant plasma glycoprotein of approximately 60 kDa that
interacts with several other protein ligands such as tropomyosin,
heparin, plasminogen, plasmin, fibrinogen, and IgG (Jones et al.,
2005). HRG has been shown to exhibit broad antimicrobial
potency (Rydengård et al., 2007), including activity against
S. pyogenes (Shannon et al., 2010). It was shown that sHIP
binds both intact HRG and HRG-derived peptides (peptides
containing consensus heparin-binding sequences) with high
affinity. Moreover, the antibacterial activity of HRG is blocked
by protein sHIP, which represents a new mechanism that can
contribute to the virulence of AP1 bacteria. In addition, we could
show that patients with severe S. pyogenes infection, in contrast
to patients with superficial and uncomplicated infections, are
more prone to develop antibodies against sHIP, which suggests
that sHIP represents a novel virulence determinant (Wisniewska
et al., 2014). Furthermore, the determination of the three-
dimensional structure of sHIP, showed that it has a tetrameric
organization composed of four helix-loop-helix motifs. A similar
structural unit can be found in the adhesion factor FadA
from Fusobacterium nucleatum. However, the two proteins
differ significantly in their respective oligomeric organization. In
FadA, the helix-loop-helix motifs form elongated fibers whereas
the sHIP monomers are organized into a compact tetrameric
structure. In order to understand the molecular prerequisites
for the observed interaction between sHIP and HRG, we have
performed extensive crystallization trials but not been able to
obtain any diffracting crystals of complexes between sHIP and
HRG or any HRG derived peptides. Due to the size of the
tetrameric sHIP, NMR experiments in solution have proven
to be very challenging and would benefit from access to a
sHIP variant with lower molecular weight and retained activity.
We have previously made the observation that the tetrameric
structure of sHIP can also be described as a dimer of dimers,
and postulated that three residues in the dimer-dimer interface
could represent important determinants for the stabilization of
the tetrameric form of sHIP. In this study, we have mutated
these three interfacial residues and thereby been able to produce
a stable dimeric variant of sHIP that was shown to be active both
in biophysical binding experiments and an antimicrobial assay.
The generation of stable dimers enabled further characterization
of the interaction between sHIP and a peptide fromHRG through
NMR experiments, providing the first molecular details of an
interaction involving this novel virulence determinant.
MATERIALS AND METHODS
Mutagenesis
The DNA sequence corresponding to residues Lys3-Met98 in the
S. pyogenes protein sHIP (UniprotID: Q99XU0) was expressed
as described previously and denoted sHIPwt (Wisniewska et al.,
2014). A protein sHIP variant, a quadruple mutant named
sHIPqp, in which Leu84, Leu88, Tyr95 were mutated to alanine,
and Cys65 was mutated to serine, was constructed using the
Quikchange XL site-directed mutagenesis kit (Agilent) following
the manufacturer’s instructions. We have previously observed
that the wildtype protein can form larger aggregates through the
exposed Cys65 residue in the absence of a reducing agent. The
mutation Cys65Ser was introduced in order to avoid the need to
use a reducing agent in subsequent experiments. As previously
noted, this mutation has no effect on the structure and function
of sHIP (Wisniewska et al., 2014). We are therefore using the
Cys65Ser mutant in all studies involving both the wildtype sHIP
and in the sHIP variant. All mutations were verified by DNA
sequence analysis. The resulting expression construct contained
a His-tag and a TEV protease cleavage site preceding the protein
sequence of interest.
Protein Expression and Purification
The protein sHIP variants sHIPwt and sHIPqp were expressed
in E. coli strain Rosetta BL21 (DE3) and purified in two steps
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using standard immobilized metal ion affinity chromatography
(IMAC) followed by proteolytic removal of the His-tag, and
reverse phase chromatography (RPC), as described previously
(Wisniewska et al., 2014). For the NMR studies, protein was
produced using minimal medium for cell growth in order
to introduce the stable isotopes 15N and 13C enabling triple-
resonance NMR experiments (Neidhardt et al., 1974). The His-
tag was removed by treatment with tobacco etch virus (TEV)
protease giving the following amino acid sequences for the
wildtype protein sHIP, sHIPwt:
SMKQDQLIVEKMEQTYEAFSPKLANLIEALDAFKEHYEE
YATLRNFYSSDEWFRLANQPWDDIPCGVLSEDLLFDMIG
DHNQLLADILDLAPIMYKHM,
and the quadruple mutant protein sHIP, sHIPqp:
SMKQDQLIVEKMEQTYEAFSPKLANLIEALDAFKEHYEE
YATLRNFYSSDEWFRLANQPWDDIPSGVLSEDLLFDMIG
DHNQLAADIADLAPIMAKHM, respectively.
The purity and mono-dispersity of the recombinant proteins
were verified by SDS-PAGE electrophoresis and mass
spectrometry.
Crystallization, X-Ray Data Collection, and
Structure Determination
Crystallization of the protein sHIP variant was carried out using
the sitting drop vapor diffusion method at 18◦C. The best crystals
were obtained from 20% PEG 6000, 0.2M calcium chloride
and 0.1M Tris, pH 8.0. Prior to plunge freezing, the crystals
were soaked for approximately 30 s in a drop of a reservoir
solution containing 20% v/v ethylene glycol as cryo-protectant.
The crystals belonged to the space group P22121 and contained
one monomer per asymmetric unit. The highest resolution data
set of 180 frames (1◦ oscillation range) was collected from
an orthorhombic crystal at Max II lab beamline I911-2, Lund,
Sweden, using a MAR CCD detector. Data were indexed and
integrated using iMOSFLM (Battye et al., 2011) and scaled using
SCALA (Evans, 2006) from the CCP4 suite of programs. The
structure was solved by molecular replacement using wild type
sHIP as the search model (PDB ID: 4MER), and refined using
REFMAC (Murshudov et al., 1997). Refinement rounds were
complemented with manual rebuilding using COOT (Emsley
et al., 2010). Water molecules were automatically inserted using
Arp/wArp and visually inspected. For further details on data
processing and refinement statistics, see Table 1. Geometry of
the model was analyzed with Molprobity (Chen et al., 2010).
Molecular graphics images were generated using the program
Pymol. The atomic coordinates and structure factors for the sHIP
mutant (sHIPqp) crystal structure have been deposited with the
protein data bank (PDB ID: 4PZ1).
Analytical Ultracentrifugation
Sedimentation velocity experiments were performed at 20◦C
and 50000 rpm using a Beckman XL-I instrument. Samples
containing either sHIPwt or sHIPqp were in 20mM MES buffer
TABLE 1 | Crystallographic data collection and refinement statistics.
Protein sHIPqp mutant
DATA COLLECTION
Beamline I911-2
Wavelength (Å) 1.038
Space group P22121
Cell dimensions
a, b, c (Å) 29.37 33.28 89.58
α, β, γ (◦) 90 90 90
Resolution (Å) 19.76–1.73 (1.82–1.73)
R_meas(%) 6.4 (14.6)
I/sigI 19.9 (10.3)
Completeness (%) 98.8 (97.8)
Multiplicity 6.4 (6.2)
REFINEMENT
Resolution (Å)a 19.76–1.73 (1.77–1.73)
No. reflections 9077 (657)
Rwork/Rfree 18.9/21.1 (20.3/38)
NO. ATOMS
Protein 792
Chloride 2
Calcium 1
Water 78
B-FACTORS (Å2)
Protein 14.8
Water 20.56
RMSD STEREOCHEMISTRYb
Bond lengths (Å) 0.011
Bond angles (◦) 1.295
RAMACHANDRAN PLOT (%)
Most favored regions 100
aValues for the highest resolution shell values are indicated in parentheses.
bRMSD, root mean square deviation.
alpha, beta, gamma refers to the unit cell axes dimensions, while alpha, beta, and gamma
in symbol refers to the inclination angles of the axes in the unit cell. The space group
number P22121 refers to the description of the symmetry of the crystal.
(2-(N-morpholino) ethanesulfonic acid), pH 5.5. The data were
analyzed with SEDFIT using a continuous c (S) distribution
(Schuck, 2000). HYDROPRO (Ortega et al., 2011) was used to
calculate the theoretical sedimentation coefficient using the PDB
IDs 4MER (sHIPwt) and 4PZ1 (sHIPqp), respectively.
Synthetic Peptide
The sequence for the HRG peptide used in the study referred
to as HRGsingle, corresponding to a single heparin-binding
motif, have the amino acid sequence GHHPHG. The peptide was
synthesized by Biosyntan GmbH (Berlin, Germany) and purity
and molecular mass were confirmed by MALDI-TOF MS.
Antimicrobial Assay
The S. pyogenes strain AP1 (40/58), was from the World Health
Organization Collaborating Centre for Reference and Research
on Streptococci, Prague, Czech Republic. The bacteria were
cultivated in THY (Todd-Hewitt broth (Difco) supplemented
with 0.2% yeast extract (Oxoid) at 37◦C and 5% CO2 until
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reaching mid-log phase (OD 620 nm approximately 0.4). The
bacterial cells were washed and resuspended in 10mM Tris-HCl,
pH 7.5, containing 5mM glucose, to a concentration of 2 × 109
cfu (colony forming unit)/ml. Subsequently, the bacteria were
diluted to a concentration of 2 × 106 cfu/ml in 10mM MES
buffer, pH 5.5, containing 5mM glucose. Fifty microliters of the
bacterial solution was incubated with recombinant His-tagged
HRG (Creative Biomart) at a concentration of 0.45 µM together
with various concentrations of protein sHIPwt or protein sHIPqp
for 40 min at 37◦C. Serial dilutions of the incubation mixtures
were plated on TH agar, plates were incubated over night at 37◦C
and the number of cfu’s were determined.
Isothermal Titration Calorimetry (ITC)
ITC experiments were performed using a VP-ITC200 instrument
(GE Healthcare). The samples were extensively dialyzed against
20mM MES buffer, pH 5.5. 0.5mM HRGsingle peptide was
titrated into 0.05mM of sHIPwt, or sHIPqp respectively. All
experiments were performed at 25◦C and run until saturation
was achieved. The data were fitted using a model describing
one independent binding site using the software provided by the
manufacturer (Wiseman et al., 1989).
NMR Experiments
Protein samples were prepared in 20 mM MES pH 5.5 with
7% (v/v) D2O for the spectrometer lock and 0.02% (w/v)
NaN3 to prevent bacterial growth in the samples. All NMR
experiments were performed at 25◦C. For the studies of the
sHIPqp/HRGsingle peptide complex, the sample contained
1.0mM of double-labeled (15N, 13C) protein sHIPqp and
1.1mM of the HRGsingle peptide. The backbone and side-chain
resonance assignment experiments were performed at 800MHz
proton resonance frequency, whereas the experiments in order
to acquire Nuclear Overhauser Enhancement (NOE) distance
restraints were acquired at 900MHz proton resonance frequency.
The assignment of the signals from sHIPqp and the HRGsingle
peptide, and collection of NOE restraints were performed by
using a combination of standard 2D and 3D triple-resonance
experiments including HNCA (Clore et al., 1990), HNCOCA
(Bax and Ikura, 1991), HNCACB (Wittekind and Mueller, 1993),
CBCACONH (Grzesiek and Bax, 1992), HCCONH (Montelione
et al., 1992), CCONH (Montelione et al., 1992), 15N-NOESY-
HSQC (Marion et al., 1989), 13C-NOESY-HSQC (separate
for aliphatic and aromatic signals; Marion et al., 1989), 2D
double-filtered NOESY (Ikura et al., 1992), and 2D single-
filtered NOESY (Ikura et al., 1992). In addition, 2D NOESY
and TOCSY experiments were acquired for the HRGsingle
peptide. Spectra were processed with NMRpipe (Delaglio et al.,
1995), applying zero-filling and linear prediction in the indirect
dimensions and solvent filter and polynomial baseline correction
in the direct dimension. CCPNMR (Vranken et al., 2005)
was used for visualization of spectra, resonance connectivity
analysis, and distance restraints (NOE) assignments. Structure
calculations were performed using an iterative procedure within
the ARIA/CNS suite of programs (Brunger et al., 1998). The
assessment of the quality of the NMR generated structural
models, were performed using the Protein Structure Validation
FIGURE 1 | Three-dimensional structure of sHIP. (A) The sHIPwt
homotetramer formed by chain A (green), chain B (red), chain C (magenta),
and chain D (cyan) using the PDB ID 4MER. (B) Molecular interface showing
the residues in contact at the interface of the two dimers of the sHIPwt
tetramer (PDB ID: 4MER). (C) The sHIPqp dimer formed by chain A (green),
and chain B (red) (PDB ID: 4PZ1). (D) Three-dimensional alignment of the
structures of the helix-loop-helix monomers of wildtype sHIP (blue) and the
sHIPqp mutant (yellow).
Suite (PSVS, Table 3; Bhattacharya et al., 2007). Molecular
graphics images were generated using the program Pymol
(Figure 5).
RESULTS
The sHIPqp Mutant Forms Stable Dimers
of Two Helix-Loop-Helix Motifs
The wildtype sHIP is composed of tetramers that can be
described as the dimer of two dimers each harboring two
helix-loop-helix motifs (Figure 1A). The hypothesis was that
the three non-polar residues at the tetramer interface (Leu84,
Leu88, Tyr95) represent important determinants for the protein
oligomerization (Figure 1B), and these residues were therefore
mutated to alanines in the sHIPqp mutant protein. The
orthorhombic crystals of the sHIPqp mutant contain one
monomer in the asymmetric unit, with a solvent content of
36%. The crystal packing shows the formation of a dimer
with a total buried surface area of 6070 Å2 as calculated by
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FIGURE 2 | Sedimentation velocity experiments for protein sHIP. The
dotted lines indicate the theoretical sedimentation coefficient for a tetramer
and a dimer respectively calculated using HYDROPRO and the structural
coordinates for protein sHIPwt (PDB ID: 4MER) and protein sHIPqp (PDB ID:
4PZ1). The wild-type sHIPwt is shown in black, and the sHIPqp mutant in red
respectively.
FIGURE 3 | Protein sHIPqp mutant inhibits the bactericidal activity of
HRG more efficiently than protein sHIP wildtype. The bactericidal effect of
HRG at 0.45 µM against S. pyogenes AP1 bacteria (2 × 106 cfu/ml) was
inhibited with sHIP wildtype (), and sHIPqp mutant () at indicated
concentrations. Experiments were repeated at least three times and mean
values ± SD are shown.
PISA server (Krissinel and Henrick, 2007). The final model
comprises residues 3-98, corresponding to the entire sHIPqp
molecule (Figure 1C). The structure is very well defined, with
an average B factor of 12.2 Å2 (10.8 Å2 and 13.6 Å2 for
main chain and side chains, respectively). Final electron density
maps are of very high quality including the loop region, which
was partially not visible in sHIP wild type (Figure 1D). All
non-glycine residues exhibit main-chain angles in the favored
regions of the Ramachandran plot as defined by the use of the
program Molprobity (Chen et al., 2010; Table 1). To provide
a quantitative analysis of the oligomeric states of the sHIP
variants, analytical ultracentrifugation was employed on sHIPwt
and the sHIPqp mutant. These experiments clearly show that the
wildtype sHIP (sHIPwt) appear as tetramers in solution whereas
the sHIP mutant (sHIPqp) exist as dimers (Figure 2). The largest
differences in the monomeric helix-loop-helix motif between the
two sHIP variants are observed in the loop region connecting
the two helices. In the sHIPqp mutant, all residues, including
side-chains, are very well defined, while in sHIPwt, some residues
could not be defined due to the absence of interpretable electron
density maps in this region (Figure 1D).
The sHIPqp Mutant Inhibits the
Antibacterial Activity of HRG
It is known that HRG has antibacterial activity including activity
against S. pyogenes (Shannon et al., 2010), and when challenged
by HRG, sHIP has been shown to rescue S. pyogenes bacteria
(Wisniewska et al., 2014). To examine whether a sHIPmutant has
the same ability, we performed an antimicrobial assay comparing
sHIPwt and sHIPqp. As shown in Figure 3, sHIPqp inhibits the
bactericidal activity of HRG to the same or even higher extent
that wildtype sHIP indicating that the dimeric mutant sHIPqp
retains its inhibitory capacity.
sHIP Binds a Single Heparin-Binding Motif
in HRG
In our previous studies we have shown that protein sHIP
binds to both HRG and HRG-derived peptides with nanomolar
to micromolar affinity, and that the histidine-rich region is
important for the interaction (Wisniewska et al., 2014). To
further dissect the molecular details in the interaction, we
investigated whether the sHIP variants are also able to bind a
single heparin-binding motif (GHHPHG) in HRG (denoted as
HRGsingle). Isothermal titration calorimetry (ITC) experiments
showed that both sHIPwt and sHIPqp binds HRGsingle with
similar micro-molar affinities, clearly indicating that the heparin-
binding motif represents an important recognition motif in HRG
for the interaction with protein sHIP (Figure 4, Table 2).
The HRG-Binding Site in sHIP Involves
Both Helix-Loop-Helix Motifs of the Dimer
The wildtype protein sHIP is a tetrameric protein with a
molecular weight of 46 kDa complicating NMR experiments in
solution due to broad and overlapping resonances. The creation
of the mutant dimeric form of sHIP, sHIPqp, and through the
verification of its functional properties, we now have access to a
smaller, yet biologically relevant system with a molecular weight
of 23kDa, which enabled detailed NMR studies in solution.
A molecular model was created with a combination of the
structure of sHIPqp (PDB ID: 4PZ1), and distance restraints
(NOEs) extracted from the NMR experiments of the complex
between sHIPqp and the HRGsingle peptide. A total of
1714 NOEs were used as distance restraints in the structure
calculations of which 321 are long-range restraints and 56
represent NOEs detected between sHIPqp and the HRGsingle
peptide (Table 3). It should be noted that this model represent
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FIGURE 4 | Isothermal titration Calorimetry (ITC) experiments showing the binding between sHIP and the HRGsingle peptide. (A) sHIPwt and HRGsingle.
(B) sHIPqp and HRGsingle. The raw data of the experiments are presented on the top panel. The area underneath each injection peak is equal to the total heat
released for that injection. When this integrated heat is plotted against the molar ratio of titrant added to the peptide solution in the cell, a complete binding isotherm
for the interaction is obtained (bottom panel). A model for either one binding site was used to fit the data. The solid line is the calculated curve using the best-fit
parameters.
TABLE 2 | Summary of thermodynamic parameters from ITC experiments
of the binding of the two sHIP variants sHIPwt and sHIPqp to the
HRGsingle peptide respectively.
Complex N (sites) Kd (µM) 1H (kcal/mol)
sHIPwt/HRGsingle 0.90 ± 0.02 1.9 ± 0.2 −15.1 ± 0.4
sHIPqp/HRGsingle 0.79 ± 0.03 2.8 ± 0.3 −12.2 ± 0.3
a preliminary description of the sHIPqp-HRGsingle complex
that will need further refinement before considered a finalized
complex structure. However, the assessment of the generated
structure shows that it is of sufficient quality to represent a
most relevant descriptive model for the complex (Table 3). The
model shows that the HRGsingle peptide binds in a pocket
created by residues from both monomeric helix-loop-helix
motifs, suggesting that the dimeric form represents the smallest
sHIP variant attainable with retained HRG-binding capacity.
Each sHIP dimer binds two HRGsingle peptides in two identical
sites (Figure 5A). The binding site includes the N-terminal part
of helix 1 of one monomer (residues Asp5-Met12), and the
end region of helix 1 of the second monomer (residues Ala41-
Ala56). For the first monomer three residues are involved in NOE
contacts with the HRGsingle peptide with primary contribution
from Ile8. For the second monomer, thirteen residues give rise
to detectable NOEs dominated by contacts involving Phe46,
Glu51, and Arg54. Moreover, the binding site does not involve
any residues in the proximity of the dimer-dimer interface in
agreement with the observation that themutant sHIPqpmaintain
its full inhibitory capacity of HRG in antimicrobial assays
(Figure 3). The two external Glycine residues of the HRGsingle
peptide, Gly-1 and Gly-6, are not involved in any interactions
with sHIP. However, the core part of the peptide, (HHPH), forms
multiple contacts with a binding pocket created by residues from
both chains of the structural framework created by the sHIP
dimer. In particular, residues His-2 and His-5 are positioned
deeply in the binding pocket, a confirmation of the peptide
backbone that is made possible due to the unique backbone
properties of the connecting Pro-4 residue (Figure 5B).
DISCUSSION
Bacterial infections represent a major challenge to human health
worldwide, a challenge increasing at an elevated pace due to
the alarming upsurge of antibiotic resistance. In order to treat
bacterial infections in the future, new therapeutic strategies need
to be developed that will require a better understanding of
the complex molecular interplay between bacterial pathogens
and their human host. S. pyogenes represents one of the most
significant bacterial pathogens in the human population. Using
mass spectrometry based proteomics, we previously identified
a novel protein and virulence factor from this bacterium
(Wisniewska et al., 2014). In this study we have extended the
structural and functional characterization of this protein to
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TABLE 3 | NMR structural restraints and structure statistics of the
sHIPqp/HRGsingle model.
Summary of experimental restraintsa
NOE-based distance constraints:
Total 1714
intra-residue [i = j] 403
sequential [| i - j | = 1] 467
medium range [1 < | i - j | < 5] 523
long range [| i - j | > 5] 321
sHIPqp/HRGsingle intermolecular NOEs 56
NOE constraints per restrained residue 17.0
Dihedral-angle constraints: 697
Total number of restricting constraints 2411
Total number of restricting constraints per restrained residueb 23.9
Restricting long-range constraints per restrained residueb 3.2
Structure Quality Factors–overall statistics
bProcheck G-factor (phi/psi only) −0.88
bProcheck G-factor (all dihedral angles) −1.04
MolProbity clashscore 73.12
cRamachandran plot (%)
Most favored regions 70.1
Additionally allowed regions 28.3
Generously allowed regions 0.5
Disallowed regions 1.1
aAnalyzed for residues 2 to 98 (sHIPqp chain A), 102-198 (sHIPqp chain B), 301-306
(HRGsingle peptide 1), and 401-406 (HRGsingle peptide 2).
bPROCHECK (Laskowski et al., 1993, 1996).
cRamachandran statistics calculated by PROCHECK (Laskowski et al., 1993, 1996).
further our understanding of the interactions between sHIP and
the human host.
The structure determination of the sHIPqp mutant showed
that the fold of the sHIP mutant and the sHIP wild type
monomers is essentially identical, displaying an elongated helix-
loop-helix motif (Figure 1). However, the most significant
difference is related to the oligomeric states of the two protein
variants. For wildtype sHIP, four monomers assemble into a
compact homotetramer, which can be described as a dimer of
dimers due to the interactions at the dimer-dimer interface.
Our previous studies showed that this interface consists of
amino acids with largely non-polar side-chains, such as Leu84,
Leu88, Tyr95, and Met98, which can be responsible for protein
oligomerization. The mutation of these residues to alanine’s
resulted in a shift in quaternary structure from tetramers to
dimers further evidenced by sedimentation velocity experiments
that clearly show that the sHIPqp mutant exists as dimers in
solution (Figure 2).
To gain further understanding of the interaction between
sHIP and HRG, a molecular model was created for the complex
between sHIPqp and a single heparin-binding motif of HRG
(HRGsingle), a peptide shown to be active in binding to both
sHIPwt and sHIPqp (Figure 4). The model shows that the
HRGsingle peptide interacts with both monomers of the helix-
loop-helix dimers, and that a proline situated in the middle
of the peptide sequence allows two histidines, His-2 and His-
5, to enter deeply into the binding pocket created by the
FIGURE 5 | Molecular model of the complex between sHIPqp and the
HRGsingle peptide. (A) sHIPqp is shown in a ribbon representation with
chain A in green and chain B in red. The HRGsingle peptide is shown in a stick
representation. (B) sHIPqp is shown in a space filling representation with chain
A in green and chain B in red. The HRGsingle peptide is shown in a stick
representation.
two sHIP monomers (Figures 5A,B). However, even if both
monomers contribute to contacts with the HRGsingle peptide,
one of the monomers clearly dominates the overall contribution
to the binding epitope for the sHIP dimer. Future studies
should involve mutagenesis experiments of both sHIP and HRG
peptides to further define the critical determinants for the
interaction.
CONCLUDING REMARKS
Through structure-based protein engineering of a selected set
of residues in the dimer-dimer interface of sHIP, we were
able to generate a dimeric form of the protein with retained
functional properties. The access to dimeric sHIP provides the
opportunity to utilize NMR techniques in order to further
elucidate interactions involving this protein. In conclusion, we
have through a combination of protein engineering, biophysics,
and structural biology methods, provided the first molecular
details describing the interaction between the antimicrobial
protein HRG and the novel virulence factor sHIP.
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